APA (7th ed.) Citation

Panoutsopoulou, K., Avgeris, M., Magkou, P., Mavridis, K., Dreyer, T., Dorn, J., . . . Scorilas, A. (2020). miR‐181a overexpression predicts the poor treatment response and early‐progression of serous ovarian cancer patients. International Journal of Cancer, 147(12), 3560-3573. https://doi.org/10.1002/ijc.33182

Chicago Style (17th ed.) Citation

Panoutsopoulou, Konstantina, et al. "MiR‐181a Overexpression Predicts the Poor Treatment Response and Early‐progression of Serous Ovarian Cancer Patients." International Journal of Cancer 147, no. 12 (2020): 3560-3573. https://doi.org/10.1002/ijc.33182.

MLA (9th ed.) Citation

Panoutsopoulou, Konstantina, et al. "MiR‐181a Overexpression Predicts the Poor Treatment Response and Early‐progression of Serous Ovarian Cancer Patients." International Journal of Cancer, vol. 147, no. 12, 2020, pp. 3560-3573, https://doi.org/10.1002/ijc.33182.